Stoke Therapeutics, Inc. (STOK)
31.86
-1.66
(-4.95%)
USD |
NASDAQ |
Dec 23, 16:00
31.69
-0.17
(-0.53%)
After-Hours: 05:30
Stoke Therapeutics SG&A Expense (TTM): 58.79M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Biogen, Inc. | 2.431B |
| Janux Therapeutics, Inc. | 39.13M |
| Insmed, Inc. | 631.20M |
| Aldeyra Therapeutics, Inc. | 9.186M |
| Mirum Pharmaceuticals, Inc. | 239.73M |